8th March 2023 Product update: newprotein staff writer
Ever After Foods Technology Offers Huge Cost Benefits for Cultivated Meat Products
Ever After Foods has officially launched its patented bioreactor platform to produce cultivated meat. Backed by the Tnuva Group, Israel’s largest food producer, the company has created the first production platform that can bring cultivated meat to the mass market at scale.
“In less than a year, Ever After Foods developed a solution unlike any other in the market through massive technological advancements that evolved the original biotech-focused technology into a food-grade platform. We see incredible potential for Ever After Foods to transform cells into high-quality cultivated meat products,” said Yaky Yanay, Pluri CEO and President, as well as Chairman of Ever After Foods.
Ever After Foods’ proprietary scalable bioreactor system for cultivated meat production overcomes the critical scaling challenge faced by industry players. Its manufacturing plants will require significantly lower capital expenditures and lower production costs – providing a 700 percent increase in productivity when compared to other cultivated meat technology platforms.
“Current cultivated meat companies all use very similar methods for growing cells and face insurmountable challenges when it comes to scaling production in a cost-effective manner. To achieve cost parity, their methods will demand huge bioreactors of more than 10,000-liters, which are infeasible for use with animal cells. Ever After Foods’ disruptive technology enables significantly higher cultivated meat production capacity, with efficiencies that lower resources and costs. We can currently produce more than 10 kilograms of cultivated meat mass with just a 35-liter bioreactor and have a proven path to scale and reach price parity,” said Ever After Foods CEO Eyal Rosenthal.
Ever After Foods achieves uncompromised meat taste and texture for cultivated products. Its cell-based technology produces cultivated meat comprised of all the essential components found in conventional meat, such as fat and muscle cells, as well as the related extracellular matrix (ECM) proteins.
While cultivated meat is not yet available for sale or consumption in the United States, given recent groundbreaking progress with the FDA and early markets like Singapore, the industry needs to scale production in preparation for global availability.
Date Published: 8th March 2023
Source article link: View
Note: This content has been edited by a newprotein.net staff writer for style and content.
Why ProteinDistillery's Egg Alternative
IFE Manufacturing Launches Seminar Programme